Valuation: Amgen Inc.

Market Cap 198B 173B 160B 148B 281B 18,865B 285B 1,910B 743B 9,260B 743B 726B 32,106B P/E 2026 *
24x
P/E 2027 * 22x
Enterprise Value 240B 210B 193B 179B 341B 22,846B 345B 2,313B 900B 11,214B 899B 880B 38,882B EV / Sales 2026 *
6.34x
EV / Sales 2027 * 6.04x
Free-Float
99.78%
Yield 2026 *
2.75%
Yield 2027 * 2.91%
1 day-2.06%
1 week+1.63%
Current month+1.19%
1 month+4.82%
3 months+6.97%
6 months+10.99%
Current year+11.96%
1 week 357.89
Extreme 357.89
375.15
1 month 334.05
Extreme 334.0501
375.15
Current year 318.21
Extreme 318.21
391.29
1 year 269.77
Extreme 269.77
391.29
3 years 218.61
Extreme 218.61
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 2012-04-30
Director of Finance/CFO 62 2010-05-12
Director of Finance/CFO 67 2019-12-31
Director TitleAgeSince
Chairman 63 2012-12-31
Director/Board Member 65 2011-12-31
Director/Board Member 71 2011-12-31
Date Insider Type Main position Quantity % Market Cap.
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
May. 18Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.06%+1.63%+22.87%+64.34% 202B
-1.14%-2.43%+53.72%+159.07% 1,082B
-1.41%+0.32%+66.23%+60.48% 633B
-2.42%+0.18%+34.59%+85.62% 461B
-0.26%+0.53%+31.00%+25.82% 338B
-2.46%-1.38%+36.42%+36.52% 299B
-2.20%-0.87%+27.50%+42.69% 291B
-1.77%+1.97%-28.85%-40.66% 222B
-1.26%+2.60%+15.98%+70.00% 163B
-2.47%-2.67%-6.54%-33.43% 139B
Average -1.42%+0.29%+25.29%+47.05% 383.1B
Weighted average by Cap. -1.46%-0.31%+37.94%+76.44%

Financials

2026 *2027 *
Net sales 37.77B 33.08B 30.46B 28.28B 53.7B 3,602B 54.42B 365B 142B 1,768B 142B 139B 6,131B 38.72B 33.91B 31.23B 28.99B 55.06B 3,693B 55.8B 374B 146B 1,813B 145B 142B 6,286B
Net income 8.23B 7.21B 6.64B 6.16B 11.7B 785B 11.86B 79.48B 30.93B 385B 30.91B 30.23B 1,336B 8.86B 7.76B 7.15B 6.64B 12.6B 846B 12.78B 85.6B 33.31B 415B 33.29B 32.56B 1,439B
Net Debt 41.74B 36.56B 33.67B 31.25B 59.35B 3,981B 60.15B 403B 157B 1,954B 157B 153B 6,776B 36.13B 31.64B 29.14B 27.05B 51.37B 3,446B 52.06B 349B 136B 1,691B 136B 133B 5,865B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
26-07-06 $366.44 -2.06% 2,837,249
26-07-02 $374.15 +3.55% 2,487,837
26-07-01 $361.33 -0.22% 2,244,791
26-06-30 $362.12 +0.44% 2,246,908
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
366.44USD
Average target price
354.76USD
Spread / Average Target
-3.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock